Endologix

Endologix

Developer and manufacturer of minimally invasive treatments for aortic disorders.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor investor

€0.0

round

$170m

Post IPO Debt
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2016201720182019202020212022
Revenues0000000000000000000000000000
% growth--(13 %)(9 %)(21 %)27 %6 %
EBITDA0000000000000000000000000000
% EBITDA margin-(10 %)(27 %)(17 %)(37 %)(15 %)-
Profit0000000000000000000000000000
% profit margin-(36 %)(50 %)(45 %)(83 %)(48 %)-
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000

Source: Company filings or news article

More about Endologix
Made with AI
Edit

Endologix is a medical device company specializing in innovative vascular therapies aimed at improving patient outcomes. The company focuses on developing groundbreaking solutions for the treatment of abdominal aortic aneurysms (AAA) and peripheral artery disease (PAD). Endologix serves healthcare professionals and patients by providing advanced medical devices that offer durable and personalized repair options. The company's flagship products include the AFX, Ovation, and ALTO systems, which are designed to preserve native bifurcation and ensure reliable, stable repairs. Endologix operates in the medical devices market and generates revenue through the sale of its specialized vascular therapy products. The business model revolves around continuous innovation and clinical excellence to meet the critical unmet needs in vascular care.

Keywords: vascular therapies, medical devices, AAA treatment, PAD solutions, healthcare professionals, patient outcomes, durable repair, personalized care, clinical excellence, innovation.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Endologix

Edit
Nellix
ACQUISITION by Endologix Oct 2010
TriVascular, Inc
ACQUISITION by Endologix Oct 2015
PQ Bypass
ACQUISITION by Endologix Apr 2021